KPV · Research brief

KPV Peptide Supplier: Sourcing and Compound Basics

Real Peptides Research TeamEditorial

Updated September 8, 20269 min read

55 WORDS

Short answer

Three amino acids. That is the entire molecule: lysine, proline and valine, joined in that order, with a molecular weight near 342 g/mol, barely larger than a caffeine molecule at 194 g/mol. KPV is a fragment cut from a hormone the body already makes, and its most useful property is defined by what was removed.

Key takeaways

KPV is the tripeptide Lys-Pro-Val, corresponding to residues 11 to 13 of alpha-melanocyte-stimulating hormone, with a molecular weight near 342 g/mol.
The fragment lacks the His-Phe-Arg-Trp message sequence of α-MSH, which is why it is studied separately from the parent hormone.
Preclinical research associates KPV with reduced NF-κB nuclear translocation and with cellular uptake through the PepT1 oligopeptide transporter.
HPLC purity and net peptide content are different measurements, and only the second tells you how much actual peptide is in the vial.
A credible KPV peptide supplier provides lot-matched HPLC and mass spectrometry documentation as standard, not on request.
Lyophilised KPV is stored at −20°C, equilibrated to room temperature before opening, and aliquoted after reconstitution to avoid repeated freeze-thaw cycles.
KPV is not FDA-approved and is sold for laboratory research use only, never for human or veterinary consumption.

We synthesise and ship this compound in small batches, and the questions arriving at any serious KPV peptide supplier follow a consistent pattern. Almost nobody asks what the sequence is. They ask what the certificate of analysis actually measured, and whether the purity figure printed on it means anything at all.

What is KPV peptide?

KPV is a synthetic tripeptide, Lys-Pro-Val, corresponding to residues 11 to 13 at the C-terminal end of alpha-melanocyte-stimulating hormone (α-MSH). Its molecular weight sits near 342 g/mol. Preclinical literature associates it with anti-inflammatory signalling activity in cell and animal models. Every legitimate KPV peptide supplier sells it strictly for laboratory research, never as an approved drug.

The common oversimplification is that KPV is simply a shrunken α-MSH doing the same job in miniature. It isn't. KPV lacks the His-Phe-Arg-Trp message sequence that drives melanocortin receptor binding and pigmentation, which is exactly why investigators isolated the fragment in the first place. What follows covers the compound background, how to read a certificate of analysis properly, storage and regulatory limits, and the sourcing questions that separate one KPV peptide supplier from the next.

The compound behind the search: where KPV comes from

KPV is the C-terminal tripeptide of α-MSH, a 13-amino-acid hormone derived from proopiomelanocortin (POMC), the precursor protein that also gives rise to ACTH and beta-endorphin. The pigment-signalling activity of α-MSH lives in its core message sequence, His-Phe-Arg-Trp, at residues 6 to 9. KPV does not contain it. That single structural fact is the reason the fragment attracted laboratory attention: researchers wanted to study the reported anti-inflammatory behaviour of the parent hormone without the melanocortin receptor activity that drives pigmentation.

What does the published preclinical work actually report? In cell culture and rodent models, KPV has been associated with reduced nuclear translocation of NF-κB (nuclear factor kappa B), the transcription factor that switches on genes coding for pro-inflammatory cytokines such as TNF-α and IL-1β. Research also describes uptake of KPV into intestinal epithelial and immune cells via PepT1, a proton-coupled oligopeptide transporter that normally ferries di- and tripeptides across cell membranes after protein digestion. Because KPV is a tripeptide, it fits that transporter's substrate profile in a way larger peptides simply cannot.

None of that is a human clinical outcome, and it should never be described as one. KPV has no approved therapeutic indication anywhere. Most people who contact a KPV peptide supplier already know the sequence and the mechanism outline. The gap in their knowledge is almost always downstream, in what the vial they receive actually contains.

Reading a certificate of analysis before you read the price

HPLC purity is the most quoted and least informative number on a peptide certificate of analysis. A reverse-phase HPLC chromatogram reporting 98% or higher tells you what fraction of the ultraviolet-absorbing material eluting from the column is your target peak. It says nothing about how much of the powder in the vial is peptide at all.

Here is the part most buyers never account for. Peptides made by solid-phase peptide synthesis (SPPS) are cleaved and purified in trifluoroacetic acid, and they leave the process as a salt. Residual TFA counterion and bound water occupy real mass inside the vial, so net peptide content, the figure produced by amino acid analysis or nitrogen determination, is routinely lower than gross vial weight. Two suppliers can both print 99% purity while shipping meaningfully different quantities of actual Lys-Pro-Val. A KPV peptide supplier that reports net peptide content alongside chromatographic purity is telling you something the 99% figure structurally cannot.

Mass spectrometry is the second document that matters. ESI-MS or MALDI-TOF confirms the observed molecular ion matches the theoretical mass for the sequence, which is identity verification, not purity verification. Purity without identity is a chromatogram of something. Identity without purity is a correct compound in unknown company. Our team has reviewed enough incoming third-party paperwork to say plainly: batches arriving with an HPLC trace and no mass spec are the single most common documentation gap in this market, and it is the first thing worth asking any KPV peptide supplier to send.

Handling, storage, and the line a KPV peptide supplier cannot cross

Lyophilised KPV is hygroscopic, which means the freeze-dried cake pulls moisture out of ambient air the moment a vial is opened at room temperature. Standard laboratory practice is storage of the sealed lyophilised powder at −20°C, allowing the vial to equilibrate to room temperature before breaking the seal so condensation forms on the outside of the glass rather than inside the cake. Once in solution, peptides are far less stable than they are as dry powder, and repeated freeze-thaw cycles degrade them, which is why aliquoting a reconstituted stock into single-use volumes before freezing is routine in working labs.

The regulatory position is not ambiguous. KPV is not FDA-approved, is not a licensed medicine, and is supplied for in-vitro and laboratory research use only. It is not for human or veterinary consumption, and no supplier can lawfully provide dosing, administration or protocol guidance for a living subject. Questions about companion animals belong with a licensed professional: talk to your veterinarian, because a KPV peptide supplier can speak to purity, batch identity and documentation, and to nothing beyond that. Everything in this article is research education rather than health guidance.

What a research buyer should expect operationally is small-batch synthesis with lot-specific paperwork, cold-chain packing appropriate to transit time, and a batch number on the vial that matches the batch number on the certificate. That last point sounds trivial until it isn't. Across our own order history, mismatched or missing lot identifiers are the reason most disputed shipments become unresolvable, because without a traceable lot there is nothing to re-test. Real Peptides issues lot-matched analytical documentation with every research compound in the catalogue for exactly that reason.

Supplier documentation compared: what each test actually proves

Every analytical document answers one narrow question and stays silent on the rest. This table shows what each item on a certificate of analysis proves, where it typically falls short, and how to weigh it when comparing sourcing options.

Documentation item	What it actually proves	Where it commonly falls short	Bottom line for a research buyer
RP-HPLC chromatogram	The proportion of UV-absorbing eluted material that corresponds to the main peak	Reveals nothing about counterion load, water content, or whether the peak is the intended sequence	Necessary but insufficient on its own; a high number here is the easiest figure in the industry to publish
Mass spectrometry (ESI-MS or MALDI-TOF)	That the observed molecular ion matches the theoretical mass of Lys-Pro-Val near 342 g/mol	Confirms identity, not quantity or contamination profile	Pair it with HPLC or you are trusting purity data on an unverified compound
Amino acid analysis / net peptide content	How much of the vial mass is genuine peptide rather than salt and moisture	Rarely supplied by default, and adds cost that budget sellers skip	The most honest cost-per-milligram comparison available between suppliers
Water content (Karl Fischer)	Residual moisture in the lyophilised cake, which affects both stability and effective mass	Snapshot at time of testing, not a guarantee across storage and transit	Useful for labs running quantitative work where vial mass drives calculations
Endotoxin testing (LAL)	Bacterial endotoxin levels, relevant to cell culture and in-vivo model work	Not standard on general research-grade material and must be requested	Ask before ordering if your assay is endotoxin-sensitive; retro-fitting the data later is impossible

What If: Sourcing and Handling Scenarios

What if my vial arrives warm after a shipping delay?

Record the arrival condition, photograph the packaging, and contact the supplier with the lot number before opening anything. Lyophilised tripeptides are considerably more temperature-tolerant than reconstituted solutions or larger proteins, and short ambient excursions during transit are common rather than catastrophic. The unanswerable question is duration and peak temperature inside the parcel, which is why a documented lot and a supplier willing to re-test or replace matters far more than the cold pack itself.

What if the certificate of analysis shows only an HPLC trace?

Request the mass spectrometry data for that specific lot before using the material in any assay. An HPLC chromatogram alone confirms that one dominant species eluted from the column, without confirming that species is Lys-Pro-Val. If the supplier cannot produce lot-specific MS data, you are working with an unverified identity, and any result you generate is uninterpretable regardless of how clean the chromatogram looks.

What if the powder looks like a thin film instead of a white cake?

Do not assume degradation, and do not assume normality either. Very small peptide quantities, typically at the low-milligram scale, frequently lyophilise into a barely visible film or a residue clinging to the vial wall rather than a fluffy cake, and this is a normal artefact of freeze-drying small masses. Colour change, clumping, or visible moisture is a different signal entirely, and a KPV peptide supplier worth using will discuss the appearance against the lot record instead of dismissing the question.

What if two suppliers quote wildly different prices for the same milligram amount?

Compare net peptide content and testing depth before comparing price, because those two variables explain most of the spread. A vial sold on gross weight with residual TFA salt and moisture, documented by a single chromatogram, costs less to produce than the same nominal mass verified by amino acid analysis and mass spectrometry. The cheaper option is not necessarily fraudulent. It is frequently a different product measured a different way.

What if I need endotoxin-tested material for cell culture work?

Specify the requirement at the point of enquiry rather than after ordering. Standard research-grade peptide is not routinely screened by LAL assay, and endotoxin contamination will confound any inflammation-related readout, which is precisely the assay category KPV research tends to occupy. Testing has to be commissioned against a specific lot, so retro-fitting the data to material already sitting in your freezer is not possible.

The unglamorous truth about research peptide sourcing

Here's the honest answer: the difference between a good and a bad KPV peptide supplier has almost nothing to do with the peptide. Lys-Pro-Val is a three-residue sequence that competent SPPS produces reliably, and the synthesis is not where things go wrong. Quality control, documentation discipline and lot traceability are where they go wrong. A supplier with rigorous analytics and a boring, unmarketable website will serve your research better than one selling the same tripeptide with dramatic language about mechanisms it cannot legally claim. Judge the paperwork, not the copywriting.

The most revealing question you can put to a KPV peptide supplier is not about purity at all. Ask what their re-test policy is when a customer disputes a lot. Suppliers who genuinely run small-batch synthesis with retained samples can answer immediately, because retained material and a lot record make re-testing trivial. Resellers repackaging bulk powder cannot, because the chain of custody breaks at the point where the label went on. That answer tells you more in ten seconds than any certificate scanned into a PDF ever will.

Questions

KPV is a synthetic tripeptide composed of lysine, proline and valine, corresponding to residues 11 to 13 at the C-terminal end of alpha-melanocyte-stimulating hormone. Its molecular weight is near 342 g/mol. Preclinical literature associates it with anti-inflammatory signalling, and it is supplied for laboratory research use only, not as an approved medicine.

KPV is produced by solid-phase peptide synthesis, usually with Fmoc chemistry, where the three residues are assembled sequentially on a resin, cleaved, purified by reverse-phase HPLC, then lyophilised into a dry powder. Because it is only three residues long, synthesis is straightforward compared with larger peptides. Batch quality is determined by purification and analytical verification rather than by the coupling steps.

Research-use-only peptides are sold to researchers, laboratories and institutions for in-vitro and laboratory investigation. They are not sold for human or veterinary consumption, and reputable suppliers state this restriction on the product page, invoice and vial label. Buyers are responsible for compliance with the research-use terms and with the regulations applying in their own jurisdiction.

Pricing varies widely by vial mass, specified purity, and how much analytical testing is included with the lot. Material sold on gross vial weight with a single HPLC chromatogram is cheaper to produce than material verified by mass spectrometry, amino acid analysis and endotoxin testing. Comparing cost per milligram of net peptide content is more meaningful than comparing headline vial prices.

There is no established human safety profile for KPV, because it is not an approved drug and has not been authorised for use in people or animals. Published work is preclinical, conducted in cell culture and animal models. Handle it in a laboratory setting under standard chemical safety practice, and treat any claim about human safety or outcomes with scepticism.

No. KPV has no FDA approval and no approved therapeutic indication in any jurisdiction we are aware of. It is supplied as a research chemical for laboratory investigation. Any supplier describing it as FDA-approved, clinically proven, or suitable for human use is making a claim that the regulatory record does not support.

KPV is the C-terminal three-residue fragment of alpha-MSH and lacks the His-Phe-Arg-Trp message sequence responsible for melanocortin receptor binding and pigmentation. Researchers use KPV specifically when they want to examine reported anti-inflammatory signalling separated from that receptor activity. KPV is also far smaller and cheaper to synthesise, and its size allows uptake through the PepT1 oligopeptide transporter.

Sealed lyophilised KPV is typically stored at −20°C and allowed to equilibrate to room temperature before the vial is opened, so condensation forms on the outside of the glass rather than in the hygroscopic cake. Once reconstituted, peptides are markedly less stable, so aliquoting into single-use volumes before freezing avoids the repeated freeze-thaw cycles that drive degradation.

Not on its own. HPLC purity describes the proportion of UV-absorbing eluted material forming the main peak, and says nothing about counterion salt, residual moisture, or compound identity. A supplier reporting 98% purity alongside mass spectrometry and net peptide content is giving you more usable information than one reporting 99.5% purity with a single chromatogram.

No. Research-use-only compounds are not for veterinary administration and are not formulated, tested or authorised for that purpose. Anyone with questions about an animal's health should talk to their veterinarian, who can assess the animal directly. A peptide supplier can speak to purity, batch identity and documentation, and nothing else.

At minimum, a lot-specific certificate of analysis containing a reverse-phase HPLC chromatogram and mass spectrometry confirming the molecular ion, with the lot number on the paperwork matching the number on the vial. Net peptide content, water content by Karl Fischer, and endotoxin testing are additional layers worth requesting depending on the assay you are running.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA